2009
DOI: 10.1177/1440783308099987
|View full text |Cite
|
Sign up to set email alerts
|

`I'd forgotten about me in all of this'

Abstract: Drawing on in-depth interviews with Australian cancer patients, this article examines their experiences of utilizing complementary and alternative medicine (CAM) within disease and treatment processes. Results illustrate the complex and often contradictory roles played by CAM within patients' therapeutic trajectories. On the one hand, their accounts illustrate the liberating and positive impacts of CAM engagement, including perceived increases in feelings of control, power and individual autonomy within therap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 41 publications
0
13
0
Order By: Relevance
“…To take a step back for a moment, there are in fact dual processes evident in the accounts presented here. The first is a moral economy of dying (see Booth, 1994) that, through cultural scripts around “good deaths” and ideas about gift/obligation, provides a relational framework for “dying well.” Intimately intertwined with quasi- or explicitly religious notions of “closure,” “acceptance,” and a “natural” end, this morality of dying produces interpersonal dilemmas; dilemmas about a responsibility to live as long as one can (see also Broom, 2009); a responsibility to reconcile existential questions before death; and a responsibility to accept one’s end (see also Broom & Cavenagh, 2011). The second concurrent process is the governance of timely deaths (Parry, 1982, 1994), human dignity, and the universally recognized right to life.…”
Section: Discussionmentioning
confidence: 99%
“…To take a step back for a moment, there are in fact dual processes evident in the accounts presented here. The first is a moral economy of dying (see Booth, 1994) that, through cultural scripts around “good deaths” and ideas about gift/obligation, provides a relational framework for “dying well.” Intimately intertwined with quasi- or explicitly religious notions of “closure,” “acceptance,” and a “natural” end, this morality of dying produces interpersonal dilemmas; dilemmas about a responsibility to live as long as one can (see also Broom, 2009); a responsibility to reconcile existential questions before death; and a responsibility to accept one’s end (see also Broom & Cavenagh, 2011). The second concurrent process is the governance of timely deaths (Parry, 1982, 1994), human dignity, and the universally recognized right to life.…”
Section: Discussionmentioning
confidence: 99%
“…Several potential health related risks of use of CM or AT should be considered such as the unregulated nature of various CAM products and CAM practitioners in many countries (World Health Organization, 2002). Studies have focused on e.g., interaction between herbs and pharmaceuticals (Izzo & Ernst, 2009), the refusal of important conventional treatment and delay of medical diagnosis (Malik & Gopalan, 2003), and problematic notions of self-healing and hyperpositivity that involve restrictive notions of self-discipline (Broom 2009b). …”
mentioning
confidence: 99%
“…In saying this—and communication provides an excellent illustration of this cultural shift—these clinicians’ accounts illustrate the broader tendency within urban Indian biomedicine and public health to view TCAM use and reliance as “backwards” and “regressive.” Moreover, their communication approaches, while illustrating patient support and the usage of TCAM, also emphasized biomedicine as exclusively able to treat cancer. In this sense, they presented TCAM in similar ways to how oncology clinicians present TCAM in Western contexts; that is, as capable of (perhaps) being an aspect of supportive care but not as having a role in the actual “treatment” of cancer (see Broom, 2009a, 2009b; Broom & Adams, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, their communication approaches, while illustrating patient support and the usage of TCAM, also emphasized biomedicine as exclusively able to treat cancer. In this sense, they presented TCAM in similar ways to how oncology clinicians present TCAM in Western contexts; that is, as capable of (perhaps) being an aspect of supportive care but not as having a role in the actual "treatment" of cancer (see Broom, 2009aBroom, , 2009b.…”
Section: Discussionmentioning
confidence: 99%